WASHINGTON, Jan 16 (Reuters) - The U.S. Supreme Court agreed on Friday to hear a patent dispute involving Amarin Pharma's (AMRN.O), opens new tab cardiovascular ‌drug Vascepa that could have broad ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results